X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (467) 467
Publication (61) 61
Book Chapter (7) 7
Patent (7) 7
Book Review (4) 4
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (173) 173
index medicus (99) 99
multiple myeloma (92) 92
oncology (87) 87
multiple myeloma - drug therapy (86) 86
hematology (85) 85
multiple myeloma - pathology (58) 58
male (50) 50
bortezomib (49) 49
female (49) 49
animals (46) 46
mice (42) 42
multiple myeloma - metabolism (39) 39
cell line, tumor (38) 38
aged (33) 33
apoptosis (33) 33
apoptosis - drug effects (32) 32
middle aged (30) 30
antineoplastic combined chemotherapy protocols - therapeutic use (28) 28
bone-marrow (27) 27
dexamethasone (27) 27
abridged index medicus (26) 26
therapy (26) 26
tumor cells, cultured (26) 26
article (25) 25
antineoplastic agents - pharmacology (24) 24
cancer (23) 23
mice, scid (23) 23
adult (22) 22
zoledronic acid (22) 22
multiple myeloma - genetics (21) 21
survival (21) 21
multiple myeloma - complications (20) 20
thalidomide - analogs & derivatives (20) 20
treatment outcome (20) 20
antineoplastic agents - therapeutic use (19) 19
multiple myeloma - immunology (19) 19
bisphosphonates (18) 18
in-vivo (18) 18
lenalidomide (18) 18
multiple myeloma - therapy (18) 18
myeloma (18) 18
care and treatment (17) 17
cell proliferation - drug effects (16) 16
chemotherapy (16) 16
health aspects (16) 16
nf-kappa-b (16) 16
stem-cell transplantation (16) 16
xenograft model antitumor assays (16) 16
activation (15) 15
multiple myeloma - diagnosis (15) 15
boronic acids - pharmacology (14) 14
drug synergism (14) 14
expression (14) 14
multiple-myeloma (14) 14
phosphorylation (14) 14
pyrazines - pharmacology (14) 14
aged, 80 and over (13) 13
antitumor-activity (13) 13
carfilzomib (13) 13
cells (13) 13
dexamethasone - administration & dosage (13) 13
drug-resistance (13) 13
growth (13) 13
lymphoid neoplasia (13) 13
patients (13) 13
disease-free survival (12) 12
interleukin-6 (12) 12
lenalidomide plus dexamethasone (12) 12
medicine, general & internal (12) 12
research (12) 12
thalidomide (12) 12
combination (11) 11
down-regulation (11) 11
interleukin-6 - pharmacology (11) 11
signal transduction - drug effects (11) 11
thalidomide - administration & dosage (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
development and progression (10) 10
in-vitro (10) 10
marrow stromal cells (10) 10
recurrence (10) 10
analysis (9) 9
bone density conservation agents - adverse effects (9) 9
bone diseases (9) 9
bone marrow (9) 9
bone marrow - pathology (9) 9
cell biology (9) 9
clinical trials (9) 9
diphosphonates - adverse effects (9) 9
diphosphonates - therapeutic use (9) 9
double-blind (9) 9
drug therapy (9) 9
molecular-mechanisms (9) 9
multiple myeloma - mortality (9) 9
multiple-myeloma cells (9) 9
newly-diagnosed myeloma (9) 9
osteoclasts - metabolism (9) 9
prognosis (9) 9
proteasome inhibitors (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Future oncology (London, England), 02/2018, Volume 14, Issue 3, p. 195
Bone is a common site for malignant involvement, either as a site of metastasis, especially in breast or prostate cancer, or as a defining characteristic of... 
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2011, Volume 17, Issue 6, pp. 1278 - 1286
Osteolytic bone disease is pathognomonic of multiple myeloma (MM) and affects more than 80% of patients. Bone disease results in skeletal-related events (SRE)... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2992 - 2992
Abstract The proto-oncogene proviral integration sites for moloney murine leukemia virus (PIM) are serine/threonine kinases currently under investigation as... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4246 - 4246
Methods: As reported previously, PVX-410 Multi-Peptide Vaccine (OncoPep, Inc.) is being developed for the treatment of SMM. PVX-410 consists of 4 human... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 5726 - 5726
Abstract The proto-oncogene proviral integration site for moloney murine leukemia virus (PIM) kinases (PIM-1, PIM-2, and PIM-3) are serine/threonine kinases... 
Journal Article
Dentistry journal, 05/2019, Volume 7, Issue 2, p. 54
We read the commentary by Fusco et al [...]. 
n/a
Journal Article
Blood, ISSN 0006-4971, 08/2010, Volume 116, Issue 5, pp. 679 - 686
Journal Article
Integrative Biology (United Kingdom), ISSN 1757-9694, 05/2016, Volume 8, Issue 5, pp. 645 - 653
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e19571 - e19571
Journal Article
Future Oncology, ISSN 1479-6694, 02/2018, Volume 14, Issue 3, pp. 195 - 203
Bone is a common site for malignant involvement, either as a site of metastasis, especially in breast or prostate cancer, or as a defining characteristic of... 
bone metastases | multiple myeloma | RANKL | bisphosphonates | zoledronic acid | denosumab | ADVANCED BREAST-CANCER | GIANT-CELL TUMOR | RANDOMIZED CONTROLLED-TRIAL | ONCOLOGY | PROSTATE-CANCER | CLINICAL-PRACTICE GUIDELINE | SKELETAL-RELATED EVENTS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | METASTASIS-FREE SURVIVAL
Journal Article
Dentistry Journal, ISSN 2304-6767, 06/2019, Volume 7, Issue 2, p. 54
We read the comment by Fusco et al [...] 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. TPS8630 - TPS8630
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 03/2015, Volume 30, Issue 3, pp. 465 - 470
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1715 - 1715
Abstract Background: Oprozomib (OPZ) is an oral epoxyketone proteasome inhibitor that has shown promising antitumor activity in patients (pts) with hematologic... 
Journal Article
ISSN 1757-9694, 5/2016, Volume 8, Issue 5, pp. 645 - 653
Protein synthesis is generally under sophisticated and dynamic regulation to meet the ever-changing demands of a cell. Global up or down-regulation of protein... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4263 - 4263
Abstract Background: Whole-genome sequencing has identified a 4-6% incidence of BRAF mutations in multiple myeloma (MM). We undertook a histology-independent,... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.